Wednesday, June 24, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 886 of 1,261
  1. US 8372380

    In vivo imaging of sulfotransferases

    The Regents of the University of California · Granted Feb 12, 2013 · Expires Feb 7, 2033

    granted
  2. US 8372984

    Dual-acting oxazole antihypertensive agents

    Theravance, Inc. · Granted Feb 12, 2013 · Expires Feb 7, 2033

    granted
  3. US 8372979

    Process for the production of high-purity 2,4′-dimethyl-3-piperidino-propiophenone (tolperisone), pharmaceutical compositions that contain the latter, as well as active ingredient formulations that contain tolperisone

    SANOCHEMIA PHARMAZEUTIKA AG · Granted Feb 12, 2013 · Expires Feb 7, 2033

    granted
  4. DE 102011080389

    Schutzfolienwechsler

    ACINO AG [DE] · Granted Feb 7, 2013 · Expires Feb 2, 2033

    granted
  5. US 8367053

    Cyclosporin analogues

    Enanta Pharmaceuticals, Inc. · Granted Feb 5, 2013 · Expires Jan 31, 2033

    granted
  6. US 8365314

    Coated elastomeric article and method for making a coated elastomeric article

    Precision Components, Inc. · Granted Feb 5, 2013 · Expires Jan 31, 2033

    granted
  7. US 8367655

    Pyridoindolobenzox—and thiazepine derivatives and uses thereof

    DAYA DRUG DISCOVERIES, INC. · Granted Feb 5, 2013 · Expires Jan 31, 2033

    granted
  8. US 8367810

    Purified plasmodium and vaccine compositions

    Sanaria Inc. · Granted Feb 5, 2013 · Expires Jan 31, 2033

    granted
  9. US 8367841

    Processes for the preparation of 1,2,4-oxadiazole benzoic acids

    PTC THERAPEUTICS, INC. · Granted Feb 5, 2013 · Expires Jan 31, 2033

    granted
  10. US 8366662

    Drug releasing coatings for medical devices

    Lutonix, Inc. · Granted Feb 5, 2013 · Expires Jan 31, 2033

    granted
  11. US 8366660

    Drug releasing coatings for medical devices

    Lutonix, Inc. · Granted Feb 5, 2013 · Expires Jan 31, 2033

    granted
  12. US 8367058

    Method for bacteriophage delivery and amplification

    The United States of America, as represented by the Secretary of Agriculture · Granted Feb 5, 2013 · Expires Jan 31, 2033

    granted
  13. US 8367074

    Recovery of recombinant human parainfluenza virus type 2 (HYPIV2) from cDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Feb 5, 2013 · Expires Jan 31, 2033

    granted
  14. US 8367105

    Compressed solid dosage form manufacturing process well-suited for use with drugs of low aqueous solubility and compressed solid dosage forms made thereby

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Feb 5, 2013 · Expires Jan 31, 2033

    granted
  15. US 8367099

    Perforated fatty acid films

    ATRIUM MEDICAL CORPORATION · Granted Feb 5, 2013 · Expires Jan 31, 2033

    granted
  16. US 8367401

    Replication competent hepatitis C virus and methods of use

    The Board of Regents of the University of Texas System · Granted Feb 5, 2013 · Expires Jan 31, 2033

    granted
  17. US 8367618

    Cyclosporin analogues for preventing or treating hepatitis C infection

    Enanta Pharmaceuticals, Inc. · Granted Feb 5, 2013 · Expires Jan 31, 2033

    granted
  18. US 8367638

    Galactose-pronged polysaccharides in a formulation for antifibrotic therapies

    GALECTIN THERAPEUTICS, INC. · Granted Feb 5, 2013 · Expires Jan 31, 2033

    granted
  19. US 8367734

    Stable epinephrine suspension formulation with high inhalation delivery efficiency

    Amphastar Pharmaceuticals, Inc. · Granted Feb 5, 2013 · Expires Jan 31, 2033

    granted
  20. US 8367120

    Method and apparatus for producing a stablized antimicrobial non-toxic electrolyzed saline solution exhibiting potential as a therapeutic

    Reoxcyn Discoveries Group, Inc. · Granted Feb 5, 2013 · Expires Jan 31, 2033

    granted
  21. US 8367660

    Modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Feb 5, 2013 · Expires Jan 31, 2033

    granted
  22. US 8367694

    Carboline derivatives useful in the inhibition of angiogenesis

    PTC THERAPEUTICS, INC. · Granted Feb 5, 2013 · Expires Jan 31, 2033

    granted
  23. US 8367691

    Modulators of muscarinic receptors

    Vertex Pharmaceuticals Incorporated · Granted Feb 5, 2013 · Expires Jan 31, 2033

    granted
  24. US 8367697

    Kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Feb 5, 2013 · Expires Jan 31, 2033

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.